The global antinuclear antibody test market size is expected to reach USD 2.36 billion by 2025 and is projected to expand at a CAGR of 12.5% over the forecast period. Rising adoption of the ANA test and an increase in government initiatives to treat autoimmune disorders are the primary factors driving the market. Furthermore, the rising incidence of autoimmune disorders is set to fuel the growth from 2018 to 2025.
From the point of view of rheumatology bioinformatic analyses, antinuclear antibody tests have gained a prominent demand to evaluate the role of SARS-CoV-2 in inflammatory and viral arthritis and are essential for diagnosis. The market experienced staggering growth in 2020 and continues to observe an upsurge in demand as studies reveal the correlation between the occurrence of viral arthritis and skin inflammation, thus making it vital to recognize the pathogenesis of COVID-19 and its clinical phenotypes.
Antinuclear Antibody Test Market Highlights
• Based on products, reagents and assay kits was the leading segment in 2017 and is anticipated to register the fastest growth by 2025 owing to the high product adoption of in clinical and research settings
• Based on technique, immunofluorescence assay accounted for the highest revenue share in 2017 owing to its high adoption compared to other available techniques
• Based on application, rheumatoid arthritis segment is projected to grow at the fastest rate due to the increasing incidence of the disease
• North America was the leading regional segment in 2017, on account of the high adoption of ANA testing, presence of a robust healthcare infrastructure, and patient awareness
For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/antinuclear-antibody-ana-test-market/request/rs1
Antinuclear Antibody Test Market Segmentation
Grand View Research has segmented the global antinuclear antibody test market on the basis of product, technique, application, end use, and region:
Antinuclear Antibody Test Product Outlook (Revenue, USD Million, 2014 – 2025)
• Reagents & Assay Kits
• Software & Services
Antinuclear Antibody Test Technique Outlook (Revenue, USD Million, 2014 – 2025)
• Immunofluorescence Assay
• Multiplex Assay
Antinuclear Antibody Test Application Outlook (Revenue, USD Million, 2014 – 2025)
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Sjogren’s Syndrome
Antinuclear Antibody Test End-use Outlook (Revenue, USD Million, 2014 – 2025)
• Clinical Laboratories
• Physician Office Laboratories
Antinuclear Antibody Test Regional Outlook (Revenue, USD Million, 2014 – 2025)
• North America
• The U.S.
• Asia Pacific
• Latin America
• Middle East & Africa
• South Africa
List of Key Players in Antinuclear Antibody Test Market
- Thermo Fisher Scientific Inc.
- Alere Inc.
- Bio-Rad Laboratories.
- Antibodies Inc.
- Immuno Concepts
- Zeus Scientific
- Inova Diagnostics
- Erba Diagnostics
- Euroimmun AG
- Trinity Biotech PLC.
Speak to Analyst @ https://www.grandviewresearch.com/inquiry/5462/ibb
Browse More Related Report:
COVID-19 Diagnostics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Reagents & Kits, Services), By Sample Type, By Test Type, By Mode, By End Use, And Segment Forecasts, 2021 – 2027
Clinical Laboratory Service Market Size, Share & Trends Analysis Report By Test Type (Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology), By Service Provider, By Application, By Region, And Segment Forecasts, 2021 – 2028
About Grand View Research
Grand View Research is an India & U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
Country: United States